The global biosimilars market size was valued at USD 28.70 billion in 2024 and is projected to reach from USD 33.16 billion ...

Syngene reported 18% YoY growth in Q3FY25 net profit. Revenue rose 11% YoY. EBITDA margin improved to 31.4%. Company expects ...

The third-quarter earnings season is in full swing, with around 59 companies set to release their results on Thursday.

Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...

Biocon advanced 2.41% to Rs 397.20 after its board is scheduled to meet on Monday, 27 January 2025, to consider and approve the raising of funds on a private placement basis.

Synthetic biology startup Fermbox works in an asset-light business model and has raised $2.5 Mn so far to build its tech ...

India's Finance Minister will present the FY25-26 Union Budget on February 1, 2025. Analysts suggest focus on manufacturing, ...

The patent expiry of key drugs in 2025-26 will open up additional market space for Indian manufacturers of generics and ...

Biocon stock price is poised for a fresh breakout from its consolidation range of 320-395, following nearly three and a half ...

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

Here's a list of buy/sell recommendations for today from three analysts: Ankush Bajaj, Raja Venkatraman, and MarketSmith ...

The Nity50 opened with a significant gap up of 102 points at 23,306.20. However, sellers intervened and pulled the index down ...